Caricamento...
Inhaled therapy in cystic fibrosis: agents, devices and regimens
KEY POINTS: There have been significant advances in both inhalation medicines and delivery devices with “intelligent nebulisers” and “dry-powder inhalers” becoming commonplace in CF care. Inhaled medicines generate high levels of a drug within the airways with limited systemic effects, offering safe...
Salvato in:
| Pubblicato in: | Breathe (Sheff) |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
European Respiratory Society
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4487378/ https://ncbi.nlm.nih.gov/pubmed/26306111 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/20734735.021014 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|